These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26253946)

  • 1. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
    Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
    Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
    Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway.
    Chen L; Lin L; Xian N; Zheng Z
    Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression.
    Wang C; Guo Y; Wang J; Min Z
    Mol Med Rep; 2015 Mar; 11(3):2147-52. PubMed ID: 25385370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells.
    Wu B; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Han J; Niu R
    Cell Prolif; 2012 Jun; 45(3):189-98. PubMed ID: 22452352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation.
    Choong LY; Lim SK; Chen Y; Loh MC; Toy W; Wong CY; Salto-Tellez M; Shah N; Lim YP
    Genes Chromosomes Cancer; 2011 Oct; 50(10):837-47. PubMed ID: 21769958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
    Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
    Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells.
    Kilker RL; Planas-Silva MD
    Cancer Res; 2006 Dec; 66(23):11478-84. PubMed ID: 17145896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
    Nilsson EM; Brokken LJ; Härkönen PL
    Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A2 positively regulates milk synthesis and proliferation of bovine mammary epithelial cells through the mTOR signaling pathway.
    Zhang M; Chen D; Zhen Z; Ao J; Yuan X; Gao X
    J Cell Physiol; 2018 Mar; 233(3):2464-2475. PubMed ID: 28771726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression.
    Chiang JK; Sung ML; Yu HR; Chang HI; Kuo HC; Tsai TC; Yen CK; Chen CN
    J Cell Physiol; 2011 Apr; 226(4):1017-26. PubMed ID: 20857402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.